# Pfizer

> Pfizer is a New York-based global biopharmaceutical company that discovers, develops, manufactures and sells prescription medicines and vaccines. Founded in 1849 by two German immigrants, it now employs roughly 75,000 people and posts north of $60 billion in annual revenue. After the Covid-19 vaccine turned it into a household name, Pfizer is spending its way into the next chapter - buying its way deep into cancer and obesity while its older blockbusters age out.

- **Founded:** 1849
- **Headquarters:** New York, New York, United States
- **Founders:** Charles Pfizer (Co-founder, Chemist), Charles F. Erhart (Co-founder, Confectioner)
- **Team size:** ~75,000 employees
- **Products:** Comirnaty, Paxlovid, Prevnar family, Eliquis, Vyndaqel / Vyndamax
- **Notable:** Co-developed one of the first authorized Covid-19 vaccines, delivered at unprecedented global scale., One of the world's largest pharmaceutical companies by revenue, with products in roughly 175 countries., Acquired Seagen for about $43 billion in 2023 to build a leading oncology franchise.

## Products & services

- **Comirnaty** — The Covid-19 mRNA vaccine developed with BioNTech that made Pfizer a household name worldwide.
- **Paxlovid** — Oral antiviral treatment for Covid-19.
- **Prevnar family** — Pneumococcal conjugate vaccines protecting against pneumonia and related infections; a long-running top seller.
- **Eliquis** — Blood thinner (anticoagulant) co-marketed with Bristol Myers Squibb; one of Pfizer's largest revenue drivers.
- **Vyndaqel / Vyndamax** — Cardiology treatment for transthyretin amyloid cardiomyopathy (ATTR-CM).
- **Oncology portfolio (incl. Seagen antibody-drug conjugates)** — Cancer therapies including targeted antibody-drug conjugates gained through the 2023 Seagen acquisition.
- **Berobenatide** — Investigational ultra-long-acting GLP-1 receptor agonist for obesity, gained via the Metsera acquisition.

## Achievements

- Co-developed one of the first authorized Covid-19 vaccines, delivered at unprecedented global scale.
- One of the world's largest pharmaceutical companies by revenue, with products in roughly 175 countries.
- Acquired Seagen for about $43 billion in 2023 to build a leading oncology franchise.
- Sustained blockbuster franchises across cardiology (Eliquis, Vyndaqel) and vaccines (Prevnar).
- 176 years of continuous operation since its 1849 founding in Brooklyn.

## Latest updates

- **2026-08** — Q2 2026 results topped estimates; Pfizer raised the low end of its full-year revenue guidance, citing an expected ~$1.5B bump from non-Covid products.
- **2026-05** — Q1 2026 revenue of about $14.45B, up 5% year over year, with strong growth from newer and acquired products.
- **2026-01** — At J.P. Morgan Healthcare Conference, Pfizer framed 2026 as a pivot from Covid to pipeline execution, targeting ~20 pivotal study starts, 8 key data readouts and 4 regulatory decisions.
- **2025-10** — Agreed to acquire Metsera, adding obesity and metabolic assets including the ultra-long-acting GLP-1 berobenatide.

## Links

- Website: https://pfizer.com
- LinkedIn: https://www.linkedin.com/company/pfizer
- Twitter/X: https://twitter.com/Pfizer
- YouTube: https://www.youtube.com/user/pfizer
- Instagram: https://www.instagram.com/pfizer
- Facebook: https://facebook.com/Pfizer

---

Profile page: https://yespress.io/pfizer
Published by YesPress — https://yespress.io
Last updated: 2026-08-13